RhumbLine Advisers’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

RhumbLine Advisers’s Portfolio ASTX Stock Details ASTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-123,871	Closed	-$1.05M	–	3060
2013 Q3	$1.05M	Buy	123,871 +662	+0.5%	+$4.19K	﹤0.01%	1748
2013 Q2	$506K	Buy	+123,209	New	+$662K	﹤0.01%	2247

RhumbLine Advisers's ASTX Position: Q4 2013 in Review

RhumbLine Advisers sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 123,871 shares — an estimated $1.05M sold.

RhumbLine Advisers first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $1.05M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

RhumbLine Advisers reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
RhumbLine Advisers sold 123,871 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $1.05M.
RhumbLine Advisers first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
RhumbLine Advisers's ASTEX PHARMACEUTICALS, INC COM position peaked at $1.05M in Q3 2013.
0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on RhumbLine Advisers's 13F filing for Q4 2013, filed 3 Feb 2014.